Acne
Drug research and approvals for acne: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 56 studies of acne are recruiting on ClinicalTrials.gov, Health Canada has authorized 25 drug trials for it since 2013, FDA has 1 approved and 0 open orphan designations naming it, and the EU has 1 authorised medicine for it.
- Recruiting worldwide: 56
- Trials authorized in Canada: 25
- FDA orphan approvals: 1
- EU medicines: 1
Recruiting Now
Newest start dates first, of 56 recruiting on ClinicalTrials.gov ↗- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living…NCT07830329 · Phase 2 · Regeneron Pharmaceuticals · starts Oct 29, 2026
- Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)NCT07863193 · Phase 3 · Sagimet Biosciences Inc. · starts Oct 21, 2026
- Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne…NCT07883538 · Not applicable · Pak Emirates Military Hospital · starts Oct 8, 2026
- Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone SkinNCT07866131 · Not applicable · WiQo S.p.A. · starts Sep 21, 2026
- Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate AcneNCT07915648 · Phase 4 · Nishtar Medical University · starts Sep 17, 2026
- Radiofrequency Treatment Versus Topical Therapy for Facial Acne VulgarisNCT07805655 · Not applicable · Jeisys Medical Inc · starts Sep 15, 2026
- Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic ProductNCT07848555 · Not applicable · Brainfarma Industria Química e Farmacêutica S/A · starts Sep 8, 2026
- Finasteride and CutibacteriumNCT07731802 · Phase 4 · University of Washington · starts Aug 31, 2026
- Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne VulgarisNCT06905210 · Phase 3 · Eurofarma Laboratorios S.A. · starts Aug 24, 2026
- Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University…NCT07822360 · Not reported · Sohag University · starts Aug 9, 2026
Trials Authorized in Canada
The 10 newest of 25; search them all in Canada trials| Jul 22, 2026 | A phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety of an acne mrna vaccine candidate in adolescents 12 to 17 years of age…579 – ACNE MRNA VACCINE | Sanofi | Pending |
| Jul 11, 2025 | A phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy and immunogenicity of an acne mrna vaccine candidate in…579 - ACNE MRNA VACCINE | Sanofi | Pending |
| Mar 14, 2025 | A phase I/ii, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an acne mrna vaccine…579 - ACNE MRNA VACCINE | Sanofi | Pending |
| Oct 15, 2024 | A phase 1, randomized, double-blind, sponsor-open, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and…PF-07905428 | Pfizer | Closed |
| Apr 27, 2021 | A phase 2, multicenter, randomized, double-blind, vehicle-controlled, clinical study to compare the safety and efficacy of idp-126 gel to epiduo forte gel…CLINDAMYCIN-BENZOYL-ADAPALENE (IDP-126) | Bausch Health | Ongoing |
| Feb 13, 2020 | Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group, clinical study comparingCLINDAMYCIN/ BENZOYL/ ADAPALENE | Bausch Health | Closed |
| Feb 13, 2020 | Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group, clinical study comparing the efficacy and safety of idp-126 gel in the…CLINDAMYCIN-BENZOYL-ADAPALENE | Bausch Health | Closed |
| Oct 4, 2019 | Phase 1, randomized, vehicle-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of repeat…BOS-356 | BOSTON PHARMACEUTICALS INC | Closed |
| Dec 31, 2018 | A phase 3, multi-center, randomized, double-blind, vehicle-controlled, 2 arm, parallel group study comparing the safety and efficacy of idp-120 gel and idp-120…IDP-120 (TRETINOIN/ BENZOYL PEROXIDE) | Dow Pharmaceutical Sciences, Inc. | Ongoing |
| Dec 31, 2018 | A phase 3, multi-center, randomized, double-blind, vehicle-controlled, 2 arm, parallel group study comparing the safety and efficacy of idp-120 gel and idp-120…IDP-120 (TRETINOIN/ BENZOYL PEROXIDE) | Bausch Health | Ongoing |
FDA Orphan Designations
Approved first, then open designations, newest first| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Nov 22, 1988 | MetrogelTreatment of acne rosacea. | Galderma Laboratories, Inc. | Approved |
Medicines Authorised in the EU
Newest first| Authorised | Medicine | Holder | EPAR |
|---|---|---|---|
| Oct 17, 2025 | Winleviclascoterone | Cassiopea S.p.A. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA